9FRS
Human PARP10 ART domain bound to a phthalazinone-based inhibitor
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | MAX IV BEAMLINE BioMAX |
| Synchrotron site | MAX IV |
| Beamline | BioMAX |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2024-03-23 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.976 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 51.197, 87.512, 57.524 |
| Unit cell angles | 90.00, 104.19, 90.00 |
Refinement procedure
| Resolution | 34.450 - 2.020 |
| R-factor | 0.18581 |
| Rwork | 0.184 |
| R-free | 0.22403 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.008 |
| RMSD bond angle | 1.580 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER |
| Refinement software | REFMAC (5.8.0425) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 55.760 | 55.760 | 2.050 |
| High resolution limit [Å] | 2.020 | 5.470 | 2.020 |
| Rmerge | 0.169 | 0.081 | 1.550 |
| Rmeas | 0.186 | 0.088 | 1.761 |
| Number of reflections | 31714 | 1680 | 1577 |
| <I/σ(I)> | 6.4 | ||
| Completeness [%] | 97.5 | ||
| Redundancy | 5.7 | ||
| CC(1/2) | 0.985 | 0.991 | 0.370 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 6 | 293 | 0.586 M NaCl 0.05M MgSO4 0.05M MES pH 6 |






